NCT06139744View on ClinicalTrials.gov

Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

November 30, 2024

Conditions

Irritable Bowel Syndrome (IBS)

Interventions

DRUG

DAO supplement

One tablet of the supplementary study product is taken orally before morning, lunch and dinner every day, and each tablet contains 4.2mg of dehydrated pea seedling powder.

DRUG

Placebo

Placebo is orally supplemented with one tablet each day before morning, lunch and dinner, and placebo does not contain dehydrated pea seedling powder 4.2mg.

Trial Locations (1)

210000

Zhenyu Zhang, Nanjing

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06139744 - Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS | Biotech Hunter | Biotech Hunter